2024年 新着論文 28 蛋白質発現分野、細胞情報学分野から論文が発表されました

Insights into the Mechanism of Catalytic Activity of Plasmodium Parasite Malate-Quinone Oxidoreductase

ACS Omega. 2024 May 1;9(19):21647-21657. doi: 10.1021/acsomega.4c02614. eCollection 2024 May 14.

Authors

Takeshi Ito  1   2 Yuma Tojo  1   3 Minori Fujii  1   3 Kohei Nishino  1 Hidetaka Kosako  1 Yasuo Shinohara  1   2

Affiliations

  • 1 Institute of Advanced Medical Sciences, Tokushima University, 3-18 Kuramoto, Tokushima 770-8503, Japan.
  • 2 Graduate School of Pharmaceutical Sciences, Tokushima University, 3-18 Kuramoto, Tokushima 770-8503, Japan.
  • 3 Faculty of Pharmaceutical Sciences, Tokushima University, 3-18 Kuramoto, Tokushima 770-8503, Japan.

Abstract

Plasmodium malate-quinone oxidoreductase (MQO) is a membrane flavoprotein catalyzing the oxidation of malate to oxaloacetate and the reduction of quinone to quinol. Recently, using a yeast expression system, we demonstrated that MQO, expressed in place of mitochondrial malate dehydrogenase (MDH), contributes to the TCA cycle and the electron transport chain in mitochondria, making MQO attractive as a promising drug target in Plasmodium malaria parasites, which lack mitochondrial MDH. However, there is little information on the structure of MQO and its catalytic mechanism, information that will be required to develop novel drugs. Here, we investigated the catalytic site of P. falciparum MQO (PfMQO) using our yeast expression system. We generated a model structure for PfMQO with the AI tool AlphaFold and used protein footprinting by acetylation with acetic anhydride to analyze the surface topology of the model, confirming the computational prediction to be reasonably accurate. Moreover, a putative catalytic site, which includes a possible flavin-binding site, was identified by this combination of protein footprinting and structural prediction model. This active site was analyzed by site-directed mutagenesis. By measuring enzyme activity and protein expression levels in the PfMQO mutants, we showed that several residues at the active site are essential for enzyme function. In addition, a single substitution mutation near the catalytic site resulted in enhanced sensitivity to ferulenol, an inhibitor of PfMQO that competes with malate for binding to the enzyme. This strongly supports the notion that the substrate binds to the proposed catalytic site. Then, the location of the catalytic site was demonstrated by structural comparison with a homologous enzyme. Finally, we used our results to propose a mechanism for the catalytic activity of MQO by reference to the mechanism of action of structurally or functionally homologous enzymes.

Conflict of interest statement

The authors declare no competing financial interest.

Full text links